Finally, a recent study found a reduction in peripheral monocyte subsets, an increase in peripheral and intrathecal activation of CD4+ and CD8+ T cells and a decrease in intrathecal levels of immune-regulatory CD56 bright natural killer cells in ALS patients [49]. The gene discussed is CD8A; the disease is amyotrophic lateral sclerosis.